An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-7547
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An extended cost-effectiveness analysis of schizophrenia treatment in India under universal public finance ; volume:14 ; number:1 ; day:8 ; month:7 ; year:2016 ; pages:1-11 ; date:12.2016
Cost effectiveness and resource allocation ; 14, Heft 1 (8.7.2016), 1-11, 12.2016
- Creator
-
Raykar, Neha
- Contributor
-
Nigam, Aditi
Chisholm, Dan
SpringerLink (Online service)
- DOI
-
10.1186/s12962-016-0058-z
- URN
-
urn:nbn:de:1111-2016071122475
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Raykar, Neha
- Nigam, Aditi
- Chisholm, Dan
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale
A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale
A cost-effectiveness analysis of a universal, preventative-focused, parent and infant programme
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
Universal distances for extended persistence
On the cost-effectiveness of PRAMs : extended abstract
Development finance for universal energy access
An extended macro-finance model with financial factors
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysis
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale